0001493152-21-030335.txt : 20211202 0001493152-21-030335.hdr.sgml : 20211202 20211202182758 ACCESSION NUMBER: 0001493152-21-030335 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211130 FILED AS OF DATE: 20211202 DATE AS OF CHANGE: 20211202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERMAN ROBERT ANDREW CENTRAL INDEX KEY: 0001258360 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38325 FILM NUMBER: 211468107 MAIL ADDRESS: STREET 1: C/O ITUS CORPORATION STREET 2: 12100 WILSHIRE BOULEVARD, SUITE 1275 CITY: LOS ANGELES STATE: CA ZIP: 90025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: enVVeno Medical Corp CENTRAL INDEX KEY: 0001661053 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330936180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 70 DOPPLER CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-261-2900 MAIL ADDRESS: STREET 1: 70 DOPPLER CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: Hancock Jaffe Laboratories, Inc. DATE OF NAME CHANGE: 20151215 4 1 ownership.xml X0306 4 2021-11-30 0 0001661053 enVVeno Medical Corp NVNO 0001258360 BERMAN ROBERT ANDREW C/O JAFFE LABORATORIES, 70 DOPPLER IRVINE CA 92618 1 1 0 0 Chief Executive Officer Common Stock 2021-11-30 4 A 0 200000 A 207736 D Stock Options 6.70 2021-11-30 4 A 0 349781 0 A 2031-11-30 Common Stock 349781 349781 D The Reporting Person was granted 200,000 restricted stock units on November 30, 2021 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The restricted stock units are subject to milestone-based vesting as follows: (i) 50% upon SAVVE (Surgical Anti-reflux Venous Valve Endoprosthesis) endpoints being achieved, and (ii) 50% upon the Pre-Market Approval of the VenoValve. The common stock options were issued to the Reporting Person on November 30, 2021 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2024. /s/ Robert A. Berman 2021-12-02